An observational study in Cataract, sponsored by Medical University of Vienna. Completed at 1 site in Austria. Open to participants aged 40 Years to 90 Years. Per ClinicalTrials.gov, last updated 2014-08-05.
Sponsored by Medical University of Vienna · Observational
The purpose of this study is to assess the axial IOL rotation after surgery with an MC 6125 AS IOL.
At the end of surgery the orientation of the IOL is documented with a short video clip via the operating microscope unit. Follow-up examinations are performed 1 hour, 1 week and 6 months after surgery. Rotational stability of the IOL is assessed using retroillumination images with a method to avoid bias from cyclorotation or head tilt.
1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.
This study's enrollment of 100 is above the median of 81 across 484 observational studies indexed under Cataract.
Browse Cataract studies →Medical University of Vienna is the lead sponsor of 1,076 studies on the registry; 177 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Eyes of patients with uni- or bilateral cataract applying for cataract surgery at the Department of Ophthalmology, Medical University Vienna.
Exclusion Criteria:
cataract surgery with implantation of intraocular lens MC 6125 AS in one eye
Procedure: cataract surgery
cataract surgery with implantation of intraocular lens
IOL rotation
The rotation of the IOLs over the first 6 postoperative months
Time frame: 6 months
This study is completed, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Vienna